title: Effectiveness of a generic chronic disease self-management program for people with type 2 diabetes: a translation study.
abstract: The purpose of the study was to determine the feasibility and efficacy of a generic chronic disease self-management program for people with type 2 diabetes.
  
  
  
  English-speaking adults with type 2 diabetes who were part of a larger US national translation study of the Stanford Chronic Disease Self-Management Program (CDSMP) were invited to be part of the current study. In addition to completing self-report questionnaires, participants submitted blood samples at baseline, 6 months, and 12 months. Of the 114 participants, half had A1C values between 6% and 6.9% and half had values of 7.0% or more.
  
  
  
  Adults with diabetes successfully participated in CDSMP workshops in a community health setting. Participants demonstrated statistically significant improvements in health indicators and behaviors but no reductions in health care utilization. Participants with A1C of 7% and above had A1C reductions at 6 months, with smaller reductions at 12 months. Those with baseline A1C less than 7% had no changes in A1C at 6 or 12 months.
  
  
  
  The results suggest that the CDSMP is a useful and appropriate program for lowering A1C among those with A1C above 7% and for improving health status for people with diabetes, regardless of their A1C.
authors.affiliation: Stanford Patient Education Research Center, Stanford, CA, USA (Dr Lorig, Dr Ritter)
authors.forename: Kate
authors.initials: K
authors.lastname: Lorig
authors.affiliation: Stanford Patient Education Research Center, Stanford, CA, USA (Dr Lorig, Dr Ritter)
authors.forename: Philip L
authors.initials: PL
authors.lastname: Ritter
authors.affiliation: Texas A&M Health Science Center, College Station, TX, USA (Dr Ory)
authors.forename: Marcia G
authors.initials: MG
authors.lastname: Ory
authors.affiliation: National Council on Aging, Washington, DC, USA (Dr Whitelaw)
authors.forename: Nancy
authors.initials: N
authors.lastname: Whitelaw
mesh_terms: D000368:Aged; D002908:Chronic Disease / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D003863:Depression / Q000453:epidemiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D004522:Educational Status; D015444:Exercise / Q000523:psychology; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D015438:Health Behavior; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D055118:Medication Adherence / Q000523:psychology; D017063:Outcome Assessment, Health Care; D010353:Patient Education as Topic; D012648:Self Care / Q000523:psychology; D057566:Self Report; D011795:Surveys and Questionnaires; D013997:Time Factors; D014481:United States / Q000453:epidemiology; D044465:White People
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human